Current Palliative Treament for GBM
https://professional.cancerconsultants.com/oncology_main_news.aspx?id=43342
PII trial results is to get something better than the dismal statistic on GBM treatments.
Temodar (temozolomide) adds 2.5 month of life to the overall GBM population
About 8% effectiveness in long term survibal, difference between T+R and R at 5 year.
About 55% of GBM patient don't respond to Temodar
+ 2.5 months = 1 Billion annual market.